Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hatch Closing Act: OTC Monograph Reform Legislation?

Executive Summary

The Utah Republican has been instrumental during his more than 40 years in office in passing legislation central to the growth of the OTC drug and dietary supplement industries. But the expansion of the OTC market is stifled by FDA's monograph system for making more ingredients available, a process agency officials say no longer works.


Related Content

Capitol Hill Calm On Regulatory Front Before Mid-Term Elections Storm
SARMs Subject To Steroids Scheduling By DEA Under Hatch, Whitehouse Bill
Exclusivity Provision Surfaces In OTC Monograph Bill
Legislators On OTC Monograph Reform: What Took You So Long?
OTC Monograph User Fees Still On The Table, But Not In Legislation
OTC Monograph User Fees Totaling $22m To $34m Floated In Senate Discussion Draft
OTC Monograph Woes No Surprise To FDA Commissioner Nominee Gottlieb
Direct OTC Purchases With Pre-Tax Accounts Swing On ACA Change, Not Repeal
Sunscreen Group Remains Cloudy About FDA's Ingredient Evaluations
“No End In Sight” For Completing OTC Monographs – CDER Director Woodcock





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts